Morpholino

MO3-rspo1

ID
ZDB-MRPHLNO-111104-5
Name
MO3-rspo1
Previous Names
  • exon 1 splice donor MO (1)
Target
Sequence
5' - AGAAACATCAGCACTCACTCCGTCT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO3-rspo1
No data available
Phenotype
Phenotype resulting from MO3-rspo1
Phenotype Fish Figures
angiogenesis disrupted, abnormal y1Tg/y1Tg + MO3-rspo1 Fig. 3 with image from Gore et al., 2011
anterior mesencephalic central artery absent, abnormal y1Tg/y1Tg + MO3-rspo1 Fig. 4 with image from Gore et al., 2011
cerebellar central artery absent, abnormal y1Tg/y1Tg + MO3-rspo1 Fig. 4 with image from Gore et al., 2011
dorsal aorta hematopoietic stem cell runx1 expression absent, abnormal WT + MO3-rspo1 Fig. S2 with image from Genthe et al., 2017
dorsal aorta hematopoietic stem cell myb expression absent, abnormal WT + MO3-rspo1 Fig. 1 with image from Genthe et al., 2017
dorsal aorta hematopoietic stem cell absent, abnormal WT + MO3-rspo1 Fig. 1 with imageFig. S2 with image from Genthe et al., 2017
dorsal aorta hematopoietic stem cell decreased amount, abnormal WT + MO3-rspo1 Fig. 1 with imageFig. 5 with image from Genthe et al., 2017
intersegmental vessel decreased amount, abnormal y1Tg/y1Tg + MO3-rspo1 Fig. 4 with image from Gore et al., 2011
intersegmental vessel decreased length, abnormal y1Tg/y1Tg + MO3-rspo1 Fig. 3 with image from Gore et al., 2011
intersegmental vessel branching involved in blood vessel morphogenesis decreased process quality, abnormal s843Tg/s843Tg + MO3-rspo1 Fig. 4 with image from Fu et al., 2022
mid cerebral vein branching involved in blood vessel morphogenesis decreased process quality, abnormal s843Tg/s843Tg + MO3-rspo1 Fig. 4 with image from Fu et al., 2022
middle mesencephalic central artery absent, abnormal y1Tg/y1Tg + MO3-rspo1 Fig. 4 with image from Gore et al., 2011
posterior mesencephalic central artery absent, abnormal y1Tg/y1Tg + MO3-rspo1 Fig. 4 with image from Gore et al., 2011
somite vegfaa expression decreased amount, abnormal WT + MO3-rspo1 Fig. 4 with imageFig. S7 with image from Genthe et al., 2017
somite dlc expression decreased amount, abnormal WT + MO3-rspo1 Fig. 3 with imageFig. S5 with imageFig. S6 with image from Genthe et al., 2017
somite wnt16 expression decreased amount, abnormal WT + MO3-rspo1 Fig. 2 with imageFig. S2 with image from Genthe et al., 2017
somite dld expression decreased amount, abnormal WT + MO3-rspo1 Fig. 3 with imageFig. S5 with imageFig. S6 with image from Genthe et al., 2017
thymus T cell rag1 expression absent, abnormal WT + MO3-rspo1 Fig. 1 with imageFig. 5 with image from Genthe et al., 2017
thymus T cell absent, abnormal WT + MO3-rspo1 Fig. 1 with imageFig. 5 with image from Genthe et al., 2017
trunk mesoderm rspo1 expression decreased amount, abnormal WT + MO3-rspo1 Fig. S2 with image from Genthe et al., 2017
vascular cord tgfb1a expression decreased amount, abnormal WT + MO3-rspo1 Fig. 4 with image from Genthe et al., 2017
vascular cord tgfb1b expression decreased amount, abnormal WT + MO3-rspo1 Fig. 4 with image from Genthe et al., 2017
whole organism wnt16 expression decreased amount, abnormal WT + MO3-rspo1 Fig. 2 with image from Genthe et al., 2017
whole organism rspo1 expression decreased amount, abnormal WT + MO3-rspo1 Fig. S1 with image from Genthe et al., 2017
whole organism vegfaa expression decreased amount, abnormal WT + MO3-rspo1 Fig. 4 with image from Genthe et al., 2017
whole organism dlc expression decreased amount, abnormal WT + MO3-rspo1 Fig. 3 with image from Genthe et al., 2017
whole organism dld expression decreased amount, abnormal WT + MO3-rspo1 Fig. 3 with image from Genthe et al., 2017
Phenotype of all Fish created by or utilizing MO3-rspo1
Phenotype Fish Conditions Figures
mid cerebral vein branching involved in blood vessel morphogenesis decreased process quality, ameliorated s843Tg/s843Tg + MO3-rspo1 chemical treatment by environment: N-methyl-N-nitrosourea Fig. 4 with image from Fu et al., 2022
intersegmental vessel branching involved in blood vessel morphogenesis decreased process quality, abnormal s843Tg/s843Tg + MO3-rspo1 standard conditions Fig. 4 with image from Fu et al., 2022
intersegmental vessel branching involved in blood vessel morphogenesis decreased process quality, ameliorated s843Tg/s843Tg + MO3-rspo1 chemical treatment by environment: N-methyl-N-nitrosourea Fig. 4 with image from Fu et al., 2022
mid cerebral vein branching involved in blood vessel morphogenesis decreased process quality, abnormal s843Tg/s843Tg + MO3-rspo1 standard conditions Fig. 4 with image from Fu et al., 2022
middle mesencephalic central artery absent, abnormal y1Tg/y1Tg + MO3-rspo1 standard conditions Fig. 4 with image from Gore et al., 2011
cerebellar central artery absent, abnormal y1Tg/y1Tg + MO3-rspo1 standard conditions Fig. 4 with image from Gore et al., 2011
posterior mesencephalic central artery absent, abnormal y1Tg/y1Tg + MO3-rspo1 standard conditions Fig. 4 with image from Gore et al., 2011
intersegmental vessel decreased length, abnormal y1Tg/y1Tg + MO3-rspo1 standard conditions Fig. 3 with image from Gore et al., 2011
intersegmental vessel decreased amount, abnormal y1Tg/y1Tg + MO3-rspo1 standard conditions Fig. 4 with image from Gore et al., 2011
angiogenesis disrupted, abnormal y1Tg/y1Tg + MO3-rspo1 standard conditions Fig. 3 with image from Gore et al., 2011
anterior mesencephalic central artery absent, abnormal y1Tg/y1Tg + MO3-rspo1 standard conditions Fig. 4 with image from Gore et al., 2011
whole organism rspo1 expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. S1 with image from Genthe et al., 2017
somite wnt16 expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 2 with imageFig. S2 with image from Genthe et al., 2017
vascular cord tgfb1a expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 4 with image from Genthe et al., 2017
dorsal aorta hematopoietic stem cell decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 1 with imageFig. 5 with image from Genthe et al., 2017
whole organism vegfaa expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 4 with image from Genthe et al., 2017
whole organism wnt16 expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 2 with image from Genthe et al., 2017
somite vegfaa expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 4 with imageFig. S7 with image from Genthe et al., 2017
whole organism dld expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 3 with image from Genthe et al., 2017
thymus T cell absent, abnormal WT + MO3-rspo1 standard conditions Fig. 1 with imageFig. 5 with image from Genthe et al., 2017
trunk mesoderm rspo1 expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. S2 with image from Genthe et al., 2017
somite dlc expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 3 with imageFig. S5 with imageFig. S6 with image from Genthe et al., 2017
dorsal aorta hematopoietic stem cell myb expression absent, abnormal WT + MO3-rspo1 standard conditions Fig. 1 with image from Genthe et al., 2017
somite dld expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 3 with imageFig. S5 with imageFig. S6 with image from Genthe et al., 2017
thymus T cell rag1 expression absent, abnormal WT + MO3-rspo1 standard conditions Fig. 1 with imageFig. 5 with image from Genthe et al., 2017
dorsal aorta hematopoietic stem cell absent, abnormal WT + MO3-rspo1 standard conditions Fig. 1 with imageFig. S2 with image from Genthe et al., 2017
vascular cord tgfb1b expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 4 with image from Genthe et al., 2017
whole organism dlc expression decreased amount, abnormal WT + MO3-rspo1 standard conditions Fig. 3 with image from Genthe et al., 2017
dorsal aorta hematopoietic stem cell runx1 expression absent, abnormal WT + MO3-rspo1 standard conditions Fig. S2 with image from Genthe et al., 2017
angiogenesis disrupted, abnormal etsrpy11/y11 + MO3-rspo1 standard conditions Fig. 2 with image from Gore et al., 2011
intersegmental vessel decreased length, abnormal etsrpy11/y11 + MO3-rspo1 standard conditions Fig. 2 with image from Gore et al., 2011
intersegmental vessel absent, abnormal y1Tg/y1Tg + MO1-flt4 + MO3-rspo1 standard conditions Fig. 7 with image from Gore et al., 2011
angiogenesis disrupted, abnormal y1Tg/y1Tg + MO1-flt4 + MO3-rspo1 standard conditions Fig. 7 with image from Gore et al., 2011
intersegmental vessel absent, abnormal y1Tg/y1Tg + MO1-vegfc + MO3-rspo1 standard conditions Fig. 7 with image from Gore et al., 2011
angiogenesis disrupted, abnormal y1Tg/y1Tg + MO1-vegfc + MO3-rspo1 standard conditions Fig. 7 with image from Gore et al., 2011
angiogenesis disrupted, abnormal y1Tg/y1Tg + MO1-wnt2bb + MO3-rspo1 standard conditions Fig. 3 with image from Gore et al., 2011
intersegmental vessel absent, abnormal y1Tg/y1Tg + MO1-wnt2bb + MO3-rspo1 standard conditions Fig. 3 with image from Gore et al., 2011
angiogenesis disrupted, abnormal etsrpy11/y11 + MO3-kremen1 + MO3-rspo1 standard conditions Fig. 2 with image from Gore et al., 2011
intersegmental vessel absent, abnormal etsrpy11/y11 + MO3-kremen1 + MO3-rspo1 standard conditions Fig. 2 with image from Gore et al., 2011
Citations